Table 1.
Severity of the infection within 6 h of ED admission | |||
---|---|---|---|
All patients | Infection group | Sepsis group | |
Demographics | |||
N (%) | 886 (100) | 454 (51.2) | 432 (48.8) |
Male (%) | 462 (52.1) | 232 (51.1) | 230 (53.2) |
Mean age (min-max) | 80 (22–102) | 80 (22–100) | 79 (25–102) |
Immunosuppressiona (%) | 131 (14.8) | 53 (11.7) | 78 (18.1) |
Outcomes | |||
ICU admissions (%) | 80 (9.0) | 7 (1.5) | 73 (16.9) |
ICU stay of ≥3 days (%) | 59 (73.8) | 4 (57.1) | 55 (75.3) |
Mortality at 48 h (%) | 25 (2.8) | 2 (0.4) | 23 (5.3) |
Focus of infection | |||
Respiratory (%) | 486 (54.9) | 209 (46.0) | 277 (64.1) |
Genitourinatory (%) | 178 (20.1) | 111 (24.5) | 67 (15.5) |
Gastrointestinal (%) | 115 (13.0) | 74 (16.3) | 41 (9.5) |
Skin/joint (%) | 66 (7.5) | 48 (10.6) | 18 (4.2) |
Central nervous system (%) | 8 (0.9) | 1 (0.2) | 7 (1.6) |
Endocarditis (%) | 4 (0.5) | 2 (0.4) | 2 (0.5) |
Other (%) | 17 (1.9) | 5 (1.1) | 12 (2.8) |
Unknownb (%) | 12 (1.4) | 5 (1.1) | 7 (1.6) |
Data are presented as n (%)
Infection group: infected patients without organ dysfunction. Sepsis group: including septic shocks; infected patients with organ dysfunction
ED emergency department, ICU intensive care unit
aIncluded human immunodeficiency virus, chronic steroid use (>1 month) and cancer
bInfection suspected, but no pathogen and/or site identified